Top Growth Stocks To Buy For 2019

Analysts expect Spirit Realty Capital Inc (NYSE:SRC) to post earnings per share (EPS) of $0.17 for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Spirit Realty Capital’s earnings, with estimates ranging from $0.16 to $0.18. Spirit Realty Capital reported earnings per share of $0.23 during the same quarter last year, which would indicate a negative year-over-year growth rate of 26.1%. The company is expected to issue its next quarterly earnings report on Thursday, November 1st.

According to Zacks, analysts expect that Spirit Realty Capital will report full year earnings of $0.74 per share for the current financial year, with EPS estimates ranging from $0.70 to $0.77. For the next financial year, analysts expect that the business will post earnings of $0.68 per share, with EPS estimates ranging from $0.66 to $0.71. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Spirit Realty Capital.

Top Growth Stocks To Buy For 2019: Del Taco Restaurants, Inc.(TACO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Del Taco Restaurants (NASDAQ:TACO) from a sell rating to a hold rating in a report issued on Thursday morning.

    Several other analysts also recently weighed in on the stock. ValuEngine raised shares of Del Taco Restaurants from a sell rating to a hold rating in a research note on Tuesday, June 5th. Zacks Investment Research raised shares of Del Taco Restaurants from a sell rating to a hold rating in a research note on Saturday, July 7th. Citigroup lifted their price target on shares of Del Taco Restaurants from $13.00 to $16.00 and gave the company a buy rating in a research note on Thursday, June 21st. TheStreet raised shares of Del Taco Restaurants from a c+ rating to a b- rating in a research note on Wednesday, July 18th. Finally, Dougherty & Co lifted their price target on shares of Del Taco Restaurants from $16.50 to $18.50 and gave the company a buy rating in a research note on Friday, July 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of Buy and an average target price of $16.06.

  • [By ]

    Del Taco Restaurants (TACO) : “We have so many others in that group, why go with this one?”

    Snap (SNAP) : “I think this one is going nowhere.”

  • [By Stephan Byrd]

    Arcos Dorados (NYSE:ARCO) and Del Taco Restaurants (NASDAQ:TACO) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

  • [By Max Byerly]

    The analysts wrote, “We maintain our Buy rating and $19 price target on Del Taco (TACO) as the company’s 3Q18 (September) draws to a close. We lower our 3Q18 (September) EPS estimate to $0.15, from $0.16, though maintain our above-guidance $0.63 EPS estimate for 2018. Our EPS estimates of $0.72 for 2019 (vs. $0.67 consensus) and $0.79 for 2020 are unchanged. We believe recent M&A activity in the industry will push TACO’s valuation multiples higher.””

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Del Taco Restaurants (TACO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Del Taco Restaurants, Inc. (NASDAQ: TACO) shares saw a slight bump on Wednesday after one key analyst upped its price target on the taco chain. The upshot from this report is tasty returns for investors.

Top Growth Stocks To Buy For 2019: Odyssey Marine Exploration Inc.(OMEX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News stories about Odyssey Marine Exploration (NASDAQ:OMEX) have trended somewhat positive recently, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Odyssey Marine Exploration earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.3184749361846 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Max Byerly]

    Odyssey Marine Exploration (NASDAQ: OMEX) and Teekay Offshore Partners (NYSE:TOO) are both small-cap transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Joseph Griffin]

    Kenon (NYSE: KEN) and Odyssey Marine Exploration (NASDAQ:OMEX) are both small-cap utilities companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Top Growth Stocks To Buy For 2019: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Array Biopharma Inc (NASDAQ:ARRY) traded down 7.2% on Friday . The company traded as low as $13.48 and last traded at $13.98. 4,906,836 shares changed hands during trading, an increase of 68% from the average session volume of 2,921,348 shares. The stock had previously closed at $15.06.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Array Biopharma (ARRY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Shane Hupp]

    Eversept Partners LLC reduced its position in shares of Array Biopharma Inc (NASDAQ:ARRY) by 71.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 357,727 shares of the biopharmaceutical company’s stock after selling 880,076 shares during the period. Array Biopharma accounts for about 2.8% of Eversept Partners LLC’s holdings, making the stock its 13th biggest position. Eversept Partners LLC owned approximately 0.17% of Array Biopharma worth $5,838,000 at the end of the most recent reporting period.

  • [By Motley Fool Transcribers]

    Array Biopharma Inc (NASDAQ:ARRY)Q4 2018 Earnings Conference CallAug. 14, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    Some of our newest plays are getting plenty of attention thanks to the biotech buying spree. Array Biopharma (NASDAQ:ARRY) is an instant winner for you thanks to yesterday’s 18% pop. And your core holding XBI continues to rake in the gains.

Leave a Reply

Your email address will not be published. Required fields are marked *